Dr. Mark Hull is a world leader in the fight against HIV. As a researcher at the BC Centre for Excellence in HIV/AIDS, Canada’s largest AIDS research, treatment and educational facility, his work focuses on infectious disease, including hep C and HIV in Aboriginal communities. A recognized expert in HIV medicine, he is working on […]
BC-CfE Director Dr. Julio Montaner shares his insight on the path forward to addressing the hepatitis C epidemic.
Talking Hep C with Dr. Montaner Read More »
Vancouver, BC July 24, 2014 – The high prevalence and incidence of hepatitis C virus (HCV) infection found among Vancouver street youth underscores the need for new health care interventions, says a new BC Centre for Excellence in HIV/AIDS study published in the British Medical Journal (Open).
‘Alarmingly’ high risk of hepatitis C infection among Vancouver street youth Read More »
As we acknowledge the annual World Hepatitis Day on July 28, the number of infections are still of concern. One in 12 people worldwide have liver disease, and greater than 3 per cent, or more than 120,000 people in BC are hepatitis B and/or C-infected.
World Hepatitis Day Sunday July 28 Read More »
Health minister Margaret MacDiarmid announced today $1.9 million in funding to support two projects that will help raise awareness about the transmission, treatment and prevention of viral hepatitis among B.C.’s Asian and South Asian population as well as throughout the province.
B.C. steps up measures to address viral hepatitis Read More »
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below
